{
    "2018-04-23": [
        [
            {
                "time": "2018-04-20",
                "original_text": "Analysts’ Recommendations for Eli Lilly & Co. on April 20",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Recommendations",
                        "Analysts"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Pre-Market Earnings Report for April 24, 2018: VZ, KO, MMM, LMT, UTX, CAT, LLY, NEE, BIIB, TRV, SHW, FCX",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Pre-Market",
                        "Report"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN",
                "features": {
                    "keywords": [
                        "Earnings",
                        "Q1",
                        "Drug/Biotech"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Eli Lilly’s 1Q18 Estimates: Revenue Growth Expected",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Revenue Growth",
                        "1Q18"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Upcoming Earnings: CAT, LLY And BA Report This Week",
                "features": {
                    "keywords": [
                        "Earnings",
                        "CAT",
                        "LLY",
                        "BA"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "industrial goods",
                        "pharmaceuticals",
                        "aerospace"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Analysts’ Estimates for Eli Lilly & Co.’s 1Q18 Earnings",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Estimates",
                        "Eli Lilly",
                        "1Q18"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Merck’s Relebactam Met Primary Endpoints in Phase 3 Study",
                "features": {
                    "keywords": [
                        "Merck",
                        "Relebactam",
                        "Phase 3",
                        "Endpoints"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "What Analysts Predict for GlaxoSmithKline’s 1Q18 Earnings",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Predict",
                        "GlaxoSmithKline",
                        "1Q18"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Elanco Announces Addition of Chief Financial Officer",
                "features": {
                    "keywords": [
                        "Elanco",
                        "CFO",
                        "Addition"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "animal health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "FDA Panel Backs Lower Dose Of Lilly-Incyte Arthritis Drug, But Not Higher Dose",
                "features": {
                    "keywords": [
                        "FDA",
                        "Panel",
                        "Lilly-Incyte",
                        "Arthritis Drug",
                        "Lower Dose",
                        "Higher Dose"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}